Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • Feature Story

SCCS Announces Safety of Two Cosmetic Ingredients (EU)

Contact UL

May 19, 2015

The European Commission's Scientific Committee on Consumer Safety (SCCS) has announced that 4-hydroxy-phenyl-β-D-glucopyranoside (β-arbutin) and nano methylene bis-benzotriazolyl tetramethyl-butylphenol (MBBT) are safe for use in cosmetic products under certain conditions. The following are its conclusions:

  • The use of β-arbutin is safe for use in face creams, with concentration limit of 7% and it does not result in the release of hydroquinone over one part per million (1 ppm)
  • The use of MBBT in its nanoform is safe for use as a UV-filter in dermally applied cosmetics with concentration limit of 10%, and the material it is used in complies with several physi-co-chemical specifications
  • In addition, the SCCS has noted that possible new data on environmental effects, irritation effects and potential bioaccumulation in selected tissues regarding MBBT must be monitored.

Source

Additional Source